Showing 1 - 7 results of 7 for search 'D. A. Abaimov', query time: 0.04s
Refine Results
-
1
An experimental study of the systemic bioavailability of the drug "Harmin hydrochloride, capsules" in comparison with native garmin on chinchilla rabbits by S. M. Adekenov, V. S. Schnaukshta, E. V. Epifantseva, D. A. Abaimov, M. G. Abdrakhmanova, A. K. Sariev
Published 2020-12-01Get full text
Article -
2
Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology by M. M. Tanashyan, A. A. Raskurazhev, A. A. Kornilova, A. A. Shabalina, D. A. Abaimov, A. V. Naminov
Published 2021-09-01Get full text
Article -
3
CARNOSINE-CONTAINING LIPOSOMES: PREPARATION AND PROPERTIES by N. A. Antonova, G. M. Sorokoumova, T. N. Fedorova, S. L. Stvolynsky, D. A. Abaimov, V. I. Popenko, V. I. Shvets
Published 2016-12-01Get full text
Article -
4
The pilot study of the basic pharmacokinetic properties of pyrrolylcarnosine — the new pyrrolic derivative of dipeptide carnosine by D. A. Abaimov, Anastasiya V. Khutorova, A. K. Sariev, O. I. Kulikova, M. A. Belousova, S. L. Stvolinsky, V. A. Migulin, T. N. Fedorova
Published 2023-07-01Get full text
Article -
5
Bioequivalence studies Nipezam retard tablets, 400 mg (JSC «Himfarm», Kazakhstan) and Finlepsin® 400 retard tablets 400 mg («Pliva Krakow, SA Pharmaceutical company», Poland) by A. K. Sariev, D. A. Abaimov, M. V. Tankevich, Y. . Budach, O. . Kurilov, S. A. Altinbekov, G. A. Dzholdygulov, V. N. Seryakov, K. S. Altinbekov
Published 2014-04-01Get full text
Article -
6
Comparative bioequivalence study of Pioglitazone tablets, 20 mg (JSC «Chimpharm», Kazakhstan) and Actos® Tablets, 30 mg («Eli Lilly Holdings, Takeda Global Research and Development... by A. K. Sariev, D. A. Abaimov, M. V. Shiryaev, E. Y. Styrova, S. A. Altynbekov, G. A. Dzholdygulov, V. N. Seryakov, Y. M. Budach, O. E. Kurilo
Published 2013-09-01Get full text
Article -
7